---
id: FC-313
type: Flashcard
created: 2025-08-08 10:01:38.952520
tags:
- Flashcard
- question
- obstetrics
topic: obstetrics
answer: C
related_articles:
- title: Evaluation of Jaundice in Adults.
  path: 2025/2025-01-evaluation-of-jaundice-in-adults.md
  similarity: 0.5
  link: '[[2025/2025-01-evaluation-of-jaundice-in-adults|Evaluation of Jaundice in
    Adults.]]'
- title: 'Gallstone Disease: Common Questions and Answers.'
  path: 2024/2024-06-gallstone-disease-common-questions-and-answers.md
  similarity: 0.471
  link: '[[2024/2024-06-gallstone-disease-common-questions-and-answers|Gallstone Disease:
    Common Questions and Answers.]]'
- title: Artificial Intelligence Scribes Shape Health Care Delivery.
  path: 2025/2025-04-artificial-intelligence-scribes-shape-health-care-delivery.md
  similarity: 0.467
  link: '[[2025/2025-04-artificial-intelligence-scribes-shape-health-care-delivery|Artificial
    Intelligence Scribes Shape Health Care Delivery.]]'
- title: 'Galactorrhea: Rapid Evidence Review.'
  path: 2022/2022-12-galactorrhea-rapid-evidence-review.md
  similarity: 0.45
  link: '[[2022/2022-12-galactorrhea-rapid-evidence-review|Galactorrhea: Rapid Evidence
    Review.]]'
- title: 'Syncope: Evaluation and Differential Diagnosis.'
  path: 2023/2023-11-syncope-evaluation-and-differential-diagnosis.md
  similarity: 0.444
  link: '[[2023/2023-11-syncope-evaluation-and-differential-diagnosis|Syncope: Evaluation
    and Differential Diagnosis.]]'
topics:
- Emergency Medicine
- Gastroenterology
- Nephrology
- Obstetrics/Gynecology
- Psychiatry
---

# Flashcard FC-313

## Question

A60-year-oldmalewithsymptomaticlowtestosteroneisstartedontransdermaltestosteronetherapy. In additiontoa PSAlevel,whichofthefollowinglaboratoryvaluesshould bemonitoredwhileonthis medication?

## Choices

A. Nootherlaboratorystudies
B. C-reactiveprotein
C. Hematocrit
D. ALTand AST

## Answer

**C**

## Explanation

Whentestosteronetherapyisstartedformalehypogonadism,baselineandperiodicmeasurementsof PSAandhematocritshould beperformed. Ifthehematocritincreasesto54 thetestosteronedosage should bestoppedordecreasedtoavoidrisksassociatedwitherythrocytosis. The American Urological Associationrecommends PSAmonitoringwithtestosteronetherapy. Arecentstudyfrom2019 showed thattreatmentwithtestosteroneincreased PSAlevelsfrombaselinelevelsbyanaverageof0.47 ng/m L. at12 months. Onlyasmallpercentageofparticipantshadanincrease1.7 ng/m L. Otherstudieshave notshownacorrelationthatisstatisticallysignificant. Liverandrenalfunctiontestsshould bemonitoredroutinelywithmanydrugsbutarenotindicatedwith testosteronetherapy. Monitoringof C-reactiveproteinisnotrecommendedduringtestosteronetherapy. e

## References

- AAFPQuestion Bank-Pythonsimplecapture.

